BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 25994188)

  • 1. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
    Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
    Trials; 2015 May; 16():222. PubMed ID: 25994188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
    Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
    Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Shenfu injection combined with sodium nitroprusside in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
    Guo B; Yang T; Nan J; Huang Q; Wang C; Xu W
    Medicine (Baltimore); 2021 Feb; 100(7):e24414. PubMed ID: 33607775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
    Guo L; Yuan H; Zhang D; Zhang J; Hua Q; Ma X; Chen K
    Medicine (Baltimore); 2020 May; 99(21):e20271. PubMed ID: 32481305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
    Gao Y; Gao Y; Zhu R; Tan X
    Medicine (Baltimore); 2021 Jan; 100(3):e24113. PubMed ID: 33546020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial.
    Kim KH; Kim HK; Hwang IC; Lee SP; Cho HJ; Kang HJ; Kim YJ; Sohn DW
    Trials; 2013 Jun; 14():188. PubMed ID: 23799908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Network Meta-analysis of different Chinese medicine injections combined with conventional western medicine in treatment of acute heart failure].
    Wang W; Kong FT; Li R; Zhao XK; Li YD; Liu K
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):251-267. PubMed ID: 38403358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
    Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
    Trials; 2015 Dec; 16():561. PubMed ID: 26654631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Jiawei Shenfu decoction on tumor necrosis factor-alpha and nuclear factor-kappa B in patients who have chronic heart failure with syndromes of deficiency of heart Yang.
    Yu M; Ye L; Bian J; Ma L; Zheng C; Guo H
    J Tradit Chin Med; 2019 Jun; 39(3):418-424. PubMed ID: 32186014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.
    Navarro-Peñalver M; Perez-Martinez MT; Gómez-Bueno M; García-Pavía P; Lupón-Rosés J; Roig-Minguell E; Comin-Colet J; Bayes-Genis A; Noguera JA; Pascual-Figal DA
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):543-550. PubMed ID: 29929385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
    Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure.
    Wei H; Wu H; Yu W; Yan X; Zhang X
    J Ethnopharmacol; 2015 Jul; 169():347-55. PubMed ID: 25937255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qing-Xin-Jie-Yu Granules in addition to conventional treatment for patients with stable coronary artery disease (QUEST Trial): study protocol for a randomized controlled trial.
    Li S; Guo M; Mao H; Gao Z; Xu H; Shi D
    Trials; 2016 Sep; 17(1):451. PubMed ID: 27628038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shenfu injection alleviates the clinical symptoms of heart failure patients combined with conventional treatment: A protocol for systematic review and meta-analysis of randomized clinical trials.
    Luo Z; Jiang M; Liu S; Duan Y; Huang J; Zeng H
    Medicine (Baltimore); 2021 Apr; 100(15):e23736. PubMed ID: 33847606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Chronic Heart Failure Patients with Qi-Yang Deficiency and Blood Stasis Resistance Syndrome by Xnmallong Injection: a Multi-center Randomized Control Study].
    Xue JG; Wang XL; Xu Y; Li FC; Liu L; Wang X; Wang JZ; Liu F
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul; 35(7):796-800. PubMed ID: 26380441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
    Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
    J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial.
    van Riet EE; Hoes AW; Limburg A; van der Hoeven H; Landman MA; Rutten FH
    BMC Cardiovasc Disord; 2014 Jan; 14():1. PubMed ID: 24400643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.